But then, upon reading the article mentionned by Deleo, I spotted the following: «So 20 - employee Unity now has a potential drug that David [the CEO] said could land in human clinical trials within two years, venture cash, respected executives, intellectual property
blanketing cellular senescence -LRB-...)»